MORE INFORMATION
FOR INVESTORS

Solutions



We’re committed to long-term solutions in disease management

ABL has three platform solutions for COVID-19 diagnostic testing:

  • Molecular: UltraGene® Combo2Screen SARS-CoV-2 Assay

    Early detection of COVID-19 through a qPCR molecular assay (coming soon).

  • Genotype: DeepChek® 8-plex SARS-CoV-2 Genotyping Assay

    (now available for Research Use Only. Not for use in diagnostic procedures). Click here for a PDF with more details.

  • Serology: SARS-CoV-2 Antibody Test (More information coming soon.)

We’re committed to long-term solutions in disease management
UltraGene® Combo2Screen SARS-CoV-2 Assay
ABLDx has submitted an EUA application to the FDA for this first COVID-19 test.

Registration Status

ABLDx has submitted an EUA application to the FDA for clinical use of the UltraGene® Combo2Screen SARS-CoV-2 Assay as a test for COVID-19.

Stay up to date on our response to COVID-19.

We'll send you updates on resources such as customer communications, fact sheets and testing information.